The authors reply
- PMID: 32931200
- PMCID: PMC7437409
- DOI: 10.1097/CCM.0000000000004530
The authors reply
Conflict of interest statement
Dr. Connors’ institution received funding from CSL Behring, and she received funding from Abbott, Portola, Takeda, and Bristol-Myers Squibb. The remaining authors have disclosed that they do not have any potential conflicts of interest.
Comment on
-
Coagulopathy of Coronavirus Disease 2019.Crit Care Med. 2020 Sep;48(9):1358-1364. doi: 10.1097/CCM.0000000000004458. Crit Care Med. 2020. PMID: 32467443 Free PMC article. Review.
-
Optimizing the Risk-Benefit Balance of Thromboprophylaxis in Critically Ill Patients With Coronavirus Disease 2019.Crit Care Med. 2020 Oct;48(10):e988-e989. doi: 10.1097/CCM.0000000000004509. Crit Care Med. 2020. PMID: 32706558 Free PMC article. No abstract available.
References
-
- Bikdeli B, Madhavan MV, Jimenez D, et al. ; Global COVID-19 Thrombosis Collaborative Group, Endorsed by the ISTH, NATF, ESVM, and the IUA, Supported by the ESC Working Group on Pulmonary Circulation and Right Ventricular Function: COVID-19 and thrombotic or thromboembolic disease: Implications for prevention, antithrombotic therapy, and follow-up: JACC state-of-the-art review. J Am Coll Cardiol 2020; 75:2950–2973 - PMC - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
